Education
About Us
Working with TipRanks
Follow Us
Cosmo Bio Co., Ltd. (JP:3386)
:3386
Total Valuation
Cosmo Bio Co., Ltd. has a market cap or net worth of ¥7.07B. The enterprise value is ¥4.45B.
Market Cap¥7.07B
Enterprise Value¥4.45B
Share Statistics
Cosmo Bio Co., Ltd. has 6,048,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding6,048,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Cosmo Bio Co., Ltd.’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 2.20%.
Return on Equity (ROE)0.03
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)2.20%
Return on Capital Employed (ROCE)0.03
Revenue Per Employee57.68M
Profits Per Employee1.51M
Employee Count174
Asset Turnover0.86
Inventory Turnover6.30
Valuation Ratios
The current PE Ratio of Cosmo Bio Co., Ltd. is 27.5. Cosmo Bio Co., Ltd.’s PEG ratio is ―.
PE Ratio27.5
PS Ratio―
PB Ratio―
Price to Fair Value0.70
Price to FCF―
Price to Operating Cash Flow0.00
PEG Ratio―
Income Statement
In the last 12 months, Cosmo Bio Co., Ltd. had revenue of 10.04B and earned 262.00M in profits. Earnings per share was 45.05.
Revenue10.04B
Gross Profit3.33B
Operating Income318.00M
Pretax Income369.00M
Net Income262.00M
EBITDA455.00M
Earnings Per Share (EPS)45.05
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Cosmo Bio Co., Ltd. pays an annual dividend of ¥25, resulting in a dividend yield of 5%
Dividend Per Share¥25
Dividend Yield5%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.27
52-Week Price Change15.03%
50-Day Moving Average1.19K
200-Day Moving Average1.13K
Relative Strength Index (RSI)54.83
Average Volume (3m)4.29K
Important Dates
Cosmo Bio Co., Ltd. upcoming earnings date is Nov 5, 2025, TBA (Confirmed).
Last Earnings DateAug 5, 2025
Next Earnings DateNov 5, 2025
Ex-Dividend DateDec 29, 2025
Financial Position
Cosmo Bio Co., Ltd. as a current ratio of 6.20, with Debt / Equity ratio of 0.22%
Current Ratio6.20
Quick Ratio5.29
Debt to Market Cap<0.01
Net Debt to EBITDA-5.22
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Cosmo Bio Co., Ltd. has paid 99.00M in taxes.
Income Tax99.00M
Effective Tax Rate0.27
Enterprise Valuation
Cosmo Bio Co., Ltd. EV to EBITDA ratio is 8.61, with an EV/FCF ratio of 156.79.
EV to Sales0.39
EV to EBITDA8.61
EV to Free Cash Flow156.79
EV to Operating Cash Flow16.26
Balance Sheet
Cosmo Bio Co., Ltd. has ¥2.50B in cash and marketable securities with ¥345.00M in debt, giving a net cash position of ¥2.15B billion.
Cash & Marketable Securities¥2.50B
Total Debt¥345.00M
Net Cash¥2.15B
Net Cash Per Share¥355.82
Tangible Book Value Per Share¥1.61K
Margins
Gross margin is 33.77%, with operating margin of 3.17%, and net profit margin of 2.61%.
Gross Margin33.77%
Operating Margin3.17%
Pretax Margin3.68%
Net Profit Margin2.61%
EBITDA Margin4.53%
EBIT Margin3.18%
Analyst Forecast
The average price target for Cosmo Bio Co., Ltd. is ¥1,257.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target¥1,257.00
Price Target Upside3.03% Upside
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast6.93%
EPS Growth Forecast-23.49%